Cresset Asset Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1761013 Chicago, IL

Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,747,782

-$212,405 QoQ

Shares Held

2,803

+10.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#543

of 1,322 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 81% Shared 0% None 19%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Dec 31, 2024

CallValue

CallShares

PutValue

$3,561,650

PutShares

5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. REGN ranks #9 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	736,708	$52,048,420
2	HALO	Halozyme Therapeutics, Inc.	260,937	$20,423,538
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,926	$3,937,081
4	EXEL	Exelixis, Inc.	70,918	$3,858,648
5	HRMY	Harmony Biosciences Holdings, Inc.	102,479	$3,731,260
6	TVTX	Travere Therapeutics, Inc.	35,433	$2,012,948
7	MRNA	Moderna, Inc.	28,359	$1,985,980
8	PVLA	Palvella Therapeutics, Inc.	11,629	$1,777,143

All Filings in REGN

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,747,782	2,803	+10.5%	Shares	Sole	2026-08-14
2026-03-31	$1,960,187	2,537	-11.1%	Shares	Sole	2026-05-15
2025-12-31	$2,203,688	2,855	+0.1%	Shares	Sole	2026-02-17
2025-09-30	$1,603,594	2,852	+1.7%	Shares	Sole	2026-01-22
2025-06-30	$1,472,100	2,804	-32.3%	Shares	Sole	2026-01-22
2025-03-31	$2,627,614	4,143	-3.0%	Shares	Sole	2025-05-13
2024-12-31	$3,561,650	5,000	-31.5%	Put	Sole	2025-02-14
2024-12-31	$3,042,361	4,271	-59.1%	Shares	Sole	2025-02-14
2024-09-30	$10,969,688	10,435	+1.9%	Shares	Defined	2024-11-14
2024-09-30	$7,674,052	7,300	-9.9%	Put	Defined	2024-11-14
2024-06-30	$8,513,343	8,100	+84.1%	Put	Defined	2024-08-14
2024-06-30	$10,759,393	10,237	+7.8%	Shares	Defined	2024-08-14
2024-03-31	$4,234,956	4,400	-8.3%	Put	Sole	2024-05-15
2024-03-31	$9,140,767	9,497	+0.3%	Shares	Defined	2024-05-15
2023-12-31	$4,215,792	4,800	+41.2%	Put	Sole	2024-02-14
2023-12-31	$8,318,284	9,471	+6.8%	Shares	Defined	2024-02-14
2023-12-31	$2,371,383	2,700	-90.2%	Call	Sole	2024-02-14
2023-09-30	$22,631,400	27,500	-89.0%	Call	Defined	2023-11-14
2023-09-30	$7,294,717	8,864	+0.5%	Shares	Defined	2023-11-14
2023-09-30	$2,798,064	3,400	-98.6%	Put	Defined	2023-11-14
2023-06-30	$179,635,000	250,000	—	Put	Sole	2023-08-14
2023-06-30	$179,635,000	250,000	—	Call	Sole	2023-08-14
2023-06-30	$6,338,241	8,821	+353.1%	Shares	Defined	2023-08-14
2023-03-31	$1,599,791	1,947	+3.9%	Shares	Sole	2023-05-12
2022-12-31	$1,352,072	1,874	-6.6%	Shares	Sole	2023-02-14
2022-09-30	$1,382,562	2,007	-1.4%	Shares	Sole	2022-11-14
2022-06-30	$1,203,540	2,036	+41.5%	Shares	Sole	2022-08-15
2022-03-31	$1,005,026	1,439	-12.4%	Shares	Sole	2022-05-16
2021-12-31	$1,036,955	1,642	+14.5%	Shares	Sole	2022-02-10
2021-09-30	$867,828	1,434	+6.7%	Shares	Sole	2021-11-15
2021-06-30	$750,677	1,344	-32.6%	Shares	Sole	2021-08-10
2021-03-31	$943,914	1,995	+59.5%	Shares	Sole	2021-05-12
2020-12-31	$604,370	1,251	-10.6%	Shares	Sole	2021-02-11
2020-09-30	$783,692	1,400	+3.6%	Shares	Sole	2020-11-13
2020-06-30	$842,551	1,351	+40.9%	Shares	Defined	2020-08-04
2020-03-31	$468,270	959	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.